<DOC>
	<DOCNO>NCT02592473</DOCNO>
	<brief_summary>The purpose project evaluate safety , efficacy , feasibility perform prostatic artery embolization ( PAE ) use endovascular technique particle embolics men suffer low urinary tract symptom ( LUTS ) due benign prostatic hyperplasia ( BPH ) .</brief_summary>
	<brief_title>Prostate Artery Embolization ( PAE ) Treatment Benign Prostatic Hyperplasia</brief_title>
	<detailed_description>This pilot study prospective , non-randomized clinical trial assess safety feasibility prostatic artery embolization . Fifty adult male subject enrol treat study . Patients provide informed consent deem eligible participation undergo prostatic artery embolization Interventional Radiology department University Virginia . After perform angiogram identify prostatic artery , tiny particle know Embozene Microspheres inject prostatic artery . Injecting particle prostatic artery slow blood flow prostate thus shrink size prostate . By shrink size prostate , hopeful provide relief low urinary tract symptom due BPH . Subjects follow 2 year part participation study .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Genital Diseases , Male</mesh_term>
	<mesh_term>Prostatism</mesh_term>
	<criteria>Patients age 4580 year Diagnosis Lower Urinary Tract Symptoms Benign Prostatic Hypertrophy minimum 6 month IPSS score initial evaluation great 7 , uroflowmetry ( Qmax ) &lt; 12mL/s ( milliliter per second ) . All prostate volume &gt; 50gm &lt; 400gm Patients urinary tract infection ( &gt; 2/year ) , prostatitis , interstitial cystitis Cases biopsy proven prostate cancer urethral cancer . Patients longterm narcotic analgesia , androgen therapy , GNRH ( gonadotropinreleasing hormone ) analogue therapy within 2 month study . Patients classify New York Heart Association Class III ( Moderate ) , high . Patients history prior pelvic irradiation . Hypersensitivity reaction contrast material manageable prophylaxis . Patients serum creatinine value &gt; 1.7mg/dl glomerular filtration rate less 50 .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Prostate Artery Embolization ( PAE )</keyword>
	<keyword>Benign Prostatic Hyperplasia ( BPH )</keyword>
	<keyword>Lower Urinary Tract Symptoms ( LUTS )</keyword>
	<keyword>BPH</keyword>
	<keyword>PAE</keyword>
	<keyword>LUTS</keyword>
	<keyword>Prostatic Artery Embolization</keyword>
</DOC>